Alkaz Uddin Selected Research

Amlodipine (Norvasc)

12/2012

Safety and efficacy of aliskiren/amlodipine/hydrochlorothiazide triple combination in patients with moderate to severe hypertension: a 54-week, open-label study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alkaz Uddin Research Topics

Disease

2	Asthma (Bronchial Asthma) 02/2024 - 01/2023
2	Chronic Urticaria 02/2024 - 01/2022
2	Peanut Hypersensitivity (Peanut Allergy) 01/2024 - 11/2022
2	Food Hypersensitivity (Food Allergy) 01/2024 - 11/2022
2	Chronic Hepatitis B 01/2016 - 01/2014
1	Rhinosinusitis 02/2024
1	Nasal Polyps (Nasal Polyp) 02/2024
1	Injection Site Reaction 01/2024
1	Hypersensitivity (Allergy) 11/2022
1	Seasonal Allergic Rhinitis (Hay Fever) 10/2020
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2014
1	Liver Diseases (Liver Disease) 01/2014
1	Fibrosis (Cirrhosis) 01/2014
1	Chronic Renal Insufficiency 01/2014
1	Hypertension (High Blood Pressure) 12/2012

Drug/Important Bio-Agent (IBA)

6	Omalizumab (Xolair)FDA Link 02/2024 - 10/2020
2	anti-IgE antibodiesIBA 02/2024 - 01/2024
2	AllergensIBA 01/2024 - 11/2022
2	Telbivudine FDA Link 01/2016 - 01/2014
1	Monoclonal AntibodiesIBA 02/2024
1	Histamine (Histamine Dihydrochloride)FDA Link 01/2022
1	Tenofovir (Viread)FDA Link 01/2016
1	CreatinineIBA 01/2014
1	Lamivudine (Epivir)FDA Link 01/2014
1	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 12/2012
1	aliskiren FDA Link 12/2012
1	Amlodipine (Norvasc)FDA LinkGeneric 12/2012

Therapy/Procedure

2	Immunotherapy 01/2024 - 11/2022
2	Therapeutics 11/2022 - 01/2014